rs745881769

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_173551.5(ANKS6):​c.193G>T​(p.Val65Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00286 in 1,264,420 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0030 ( 10 hom. )

Consequence

ANKS6
NM_173551.5 missense

Scores

1
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: -0.640

Publications

0 publications found
Variant links:
Genes affected
ANKS6 (HGNC:26724): (ankyrin repeat and sterile alpha motif domain containing 6) This gene encodes a protein containing multiple ankyrin repeats and a SAM domain. It is thought that this protein may localize to the proximal region of the primary cilium, and may play a role in renal and cardiovascular development. Mutations in this gene have been shown to cause a form of nephronophthisis (NPHP16), a chronic tubulo-interstitial nephritis. [provided by RefSeq, Jul 2015]
ANKS6 Gene-Disease associations (from GenCC):
  • nephronophthisis 16
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • nephronophthisis 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • nephronophthisis 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005586326).
BP6
Variant 9-98796299-C-A is Benign according to our data. Variant chr9-98796299-C-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 474447.
BS2
High Homozygotes in GnomAdExome4 at 10 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANKS6NM_173551.5 linkc.193G>T p.Val65Phe missense_variant Exon 1 of 15 ENST00000353234.5 NP_775822.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANKS6ENST00000353234.5 linkc.193G>T p.Val65Phe missense_variant Exon 1 of 15 1 NM_173551.5 ENSP00000297837.6
ANKS6ENST00000471846.1 linkn.241G>T non_coding_transcript_exon_variant Exon 1 of 2 2
ANKS6ENST00000375019.6 linkc.-42+385G>T intron_variant Intron 1 of 14 5 ENSP00000364159.2

Frequencies

GnomAD3 genomes
AF:
0.00198
AC:
298
AN:
150438
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000606
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00126
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.00227
Gnomad FIN
AF:
0.00336
Gnomad MID
AF:
0.00321
Gnomad NFE
AF:
0.00293
Gnomad OTH
AF:
0.00436
GnomAD2 exomes
AF:
0.00377
AC:
48
AN:
12730
AF XY:
0.00408
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00121
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00934
Gnomad NFE exome
AF:
0.00437
Gnomad OTH exome
AF:
0.00226
GnomAD4 exome
AF:
0.00297
AC:
3312
AN:
1113874
Hom.:
10
Cov.:
30
AF XY:
0.00293
AC XY:
1562
AN XY:
533436
show subpopulations
African (AFR)
AF:
0.000172
AC:
4
AN:
23320
American (AMR)
AF:
0.000509
AC:
6
AN:
11784
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
15394
East Asian (EAS)
AF:
0.000230
AC:
6
AN:
26054
South Asian (SAS)
AF:
0.00277
AC:
81
AN:
29240
European-Finnish (FIN)
AF:
0.00575
AC:
134
AN:
23308
Middle Eastern (MID)
AF:
0.00165
AC:
5
AN:
3034
European-Non Finnish (NFE)
AF:
0.00318
AC:
2981
AN:
937158
Other (OTH)
AF:
0.00213
AC:
95
AN:
44582
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
175
350
525
700
875
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
124
248
372
496
620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00198
AC:
298
AN:
150546
Hom.:
0
Cov.:
33
AF XY:
0.00188
AC XY:
138
AN XY:
73456
show subpopulations
African (AFR)
AF:
0.000604
AC:
25
AN:
41394
American (AMR)
AF:
0.00126
AC:
19
AN:
15132
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3432
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5164
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4832
European-Finnish (FIN)
AF:
0.00336
AC:
34
AN:
10120
Middle Eastern (MID)
AF:
0.00345
AC:
1
AN:
290
European-Non Finnish (NFE)
AF:
0.00293
AC:
197
AN:
67184
Other (OTH)
AF:
0.00431
AC:
9
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
19
37
56
74
93
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00217
Hom.:
0
Bravo
AF:
0.00180
ExAC
AF:
0.00113
AC:
12

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Sep 20, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.193G>T (p.V65F) alteration is located in exon 1 (coding exon 1) of the ANKS6 gene. This alteration results from a G to T substitution at nucleotide position 193, causing the valine (V) at amino acid position 65 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

Nephronophthisis 16 Benign:1
Dec 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ANKS6-related disorder Benign:1
Aug 19, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
8.2
DANN
Benign
0.60
DEOGEN2
Benign
0.011
T
Eigen
Benign
-0.88
Eigen_PC
Benign
-0.98
LIST_S2
Benign
0.41
T
M_CAP
Benign
0.0049
T
MetaRNN
Benign
0.0056
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
1.4
L
PhyloP100
-0.64
PrimateAI
Pathogenic
0.90
D
PROVEAN
Benign
-0.62
N
Sift
Benign
0.14
T
Sift4G
Benign
0.10
T
Vest4
0.33
ClinPred
0.016
T
GERP RS
0.71
PromoterAI
0.010
Neutral
RBP_binding_hub_radar
1.1
RBP_regulation_power_radar
2.2
Varity_R
0.14
gMVP
0.43
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs745881769; hg19: chr9-101558581; API